Kawaguchi, Y., Okano, T., Imai, K., Maehara, S., Maeda, J., Yoshida, K., . . . Ikeda, N. (2019). Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II–III. Oncol Lett.
Chicago ZitierstilKawaguchi, Yohei, et al. "Epidermal Growth Factor Receptor Mutation Subtype Has Differential Effects On Adjuvant Chemotherapy for Resected Adenocarcinoma Pathological Stages II–III." Oncol Lett 2019.
MLA ZitierstilKawaguchi, Yohei, et al. "Epidermal Growth Factor Receptor Mutation Subtype Has Differential Effects On Adjuvant Chemotherapy for Resected Adenocarcinoma Pathological Stages II–III." Oncol Lett 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.